HOMA-IR Calculator
Estimate insulin resistance (HOMA-IR), beta-cell function (HOMA-%B), insulin sensitivity (HOMA-%S) and QUICKI from a fasting glucose and fasting insulin measurement.
Enter fasting values
Tap either unit badge to switch both fields between conventional (mg/dL, µIU/mL) and SI (mmol/L, pmol/L) units.
HOMA-IR
–
Related indices
HOMA-%B
–
Beta-cell function (%)
HOMA-%S
–
Insulin sensitivity (%)
QUICKI
–
Quantitative insulin sensitivity check
HOMA-IR Interpretation Ranges
Optimal
<1.0
Insulin sensitive
Normal
1.0–1.9
Within usual range
Early Resistance
2.0–2.9
Borderline / early IR
Significant
≥3.0
Likely insulin resistant
Formula
HOMA-IR = (Fasting Insulin (µIU/mL) × Fasting Glucose (mmol/L)) ÷ 22.5
HOMA-IR = (Fasting Insulin (µIU/mL) × Fasting Glucose (mg/dL)) ÷ 405
HOMA-%B = (20 × Insulin (µIU/mL)) ÷ (Glucose (mmol/L) − 3.5)
HOMA-%S = 100 ÷ HOMA-IR
QUICKI = 1 ÷ (log₁₀ Insulin (µIU/mL) + log₁₀ Glucose (mg/dL))
About HOMA-IR
The Homeostatic Model Assessment (HOMA) estimates insulin resistance and beta-cell function from paired fasting glucose and insulin measurements, based on the feedback relationship between the pancreas and liver in the fasting state. It is a simple, inexpensive surrogate for the hyperinsulinemic-euglycemic clamp, widely used in epidemiology and clinical research.
Conditions associated with raised HOMA-IR
- Obesity, particularly central/visceral adiposity
- Metabolic syndrome and prediabetes / type 2 diabetes
- Polycystic ovary syndrome (PCOS)
- Non-alcoholic fatty liver disease (NAFLD)
- Certain medications (e.g. glucocorticoids) and acute illness or stress
Limitations
- There is no universally accepted HOMA-IR cutoff — thresholds differ by ethnicity, age, BMI, and the insulin assay used
- Not valid for patients on exogenous insulin therapy, and unreliable in advanced beta-cell failure or when fasting glucose is markedly elevated
- HOMA-%B is undefined when fasting glucose is 3.5 mmol/L (63 mg/dL) or below
- Fasting insulin measurement is not well standardized between assays, which can shift results between laboratories
- A single measurement has day-to-day variability — interpret alongside clinical context, HbA1c, and lipid profile
Share this tool

